We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Tag: COVID-19
MedXY News
EnglishTag

COVID-19

Ask MedXY AI
type 2 diabetesclinical trialheart failureimmunotherapyobesitycardiovascular riskatrial fibrillationbiomarkerscritical careclinical trialsHypertensionartificial intelligenceCardiologyoncologypublic healthtype 1 diabetesdiabetesMortalityAlzheimer's diseasecardiovascular diseasebreast cancerepidemiology

Latest news

Tag

Evolving Patterns of Clinical Testing for SARS-CoV-2, Influenza, and RSV in Hospitalized Youths (2016–2024): Insights and Implications
Infectious DiseasesCOVID-19influenza

Evolving Patterns of Clinical Testing for SARS-CoV-2, Influenza, and RSV in Hospitalized Youths (2016–2024): Insights and Implications

By MedXY|Oct 27, 2025

This study evaluates clinical testing trends for COVID-19, influenza, and RSV among hospitalized children from 2016 to 2024, revealing shifts in testing frequency and identifying factors influencing test utilization.

Global Mortality Trends 1990-2023: Insights from the GBD 2023 Study on Causes of Death
Internal MedicineCOVID-19Global Burden of Disease
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story

Global Mortality Trends 1990-2023: Insights from the GBD 2023 Study on Causes of Death

By MedXY|Oct 20, 2025

The GBD 2023 Study integrates data from 204 countries to reveal shifting global mortality patterns, emphasizing the impact of COVID-19, declining vaccine-preventable deaths, and rising non-communicable diseases, highlighting critical areas

Metformin and COVID-19 Symptom Resolution: Evidence from the ACTIV-6 Randomized Clinical Trial
Clinical UpdatesCOVID-19metformin

Metformin and COVID-19 Symptom Resolution: Evidence from the ACTIV-6 Randomized Clinical Trial

By MedXY|Oct 7, 2025

This review synthesizes recent evidence from the ACTIV-6 trial showing metformin does not significantly reduce symptom duration in low-risk adults with COVID-19, addressing safety, clinical outcomes, and translational insights.

FDA Approves Updated COVID-19 Vaccines Targeting Latest LP.8.1 Variant for High-Risk and Older Adults
Public HealthCOVID-19FDA approval

FDA Approves Updated COVID-19 Vaccines Targeting Latest LP.8.1 Variant for High-Risk and Older Adults

By MedXY|Oct 5, 2025

The FDA has authorized updated COVID-19 vaccines from Pfizer and Moderna designed to target the LP.8.1 sublineage, expanding vaccination to adults over 65 and individuals with high-risk conditions, enhancing immune defense against evolving

Depression and Anxiety Rates Increased Among Racial Groups During the Pandemic
PsychiatryCOVID-19mental health

Depression and Anxiety Rates Increased Among Racial Groups During the Pandemic

By MedXY|Oct 4, 2025

A survey reveals significant increases in depression and anxiety rates among various racial groups during the COVID-19 pandemic, highlighting ongoing racial health disparities.

Kidney-transplant recipients benefit from COVID-19 vaccination
Infectious DiseasesCOVID-19kidney transplant

Kidney-transplant recipients benefit from COVID-19 vaccination

By MedXY|Oct 4, 2025

Kidney-transplant recipients on long-term kidney replacement therapy demonstrate significant reductions in COVID-19-related hospitalizations and mortality following three or more vaccine doses, supporting booster vaccinations in this vulner

Common Cold and Reduced COVID-19 Risk: Insights from the HEROS Cohort Study on Rhinovirus-Induced Airway Antiviral Responses
Infectious Diseasesantiviral immunityCOVID-19

Common Cold and Reduced COVID-19 Risk: Insights from the HEROS Cohort Study on Rhinovirus-Induced Airway Antiviral Responses

By MedXY|Oct 4, 2025

Recent rhinovirus infection may nearly halve COVID-19 risk and reduce viral load by triggering airway antiviral gene expression, partially explaining children’s milder COVID-19 outcomes.

Symptomatic Respiratory Disease and COVID-19 Testing Among Healthcare Workers: Insights from the Post-Pandemic Era in Ireland
Clinical UpdatesCOVID-19healthcare workers

Symptomatic Respiratory Disease and COVID-19 Testing Among Healthcare Workers: Insights from the Post-Pandemic Era in Ireland

By MedXY|Oct 4, 2025

A recent Irish study reveals that 6 in 10 healthcare workers with respiratory symptoms test for COVID-19, while vaccination coverage remains low, highlighting ongoing risks and the need for enhanced infection control and vaccination strateg

COVID reinfection may raise risk of persistent symptoms by 35%
Clinical UpdatesCOVID-19epidemiology

COVID reinfection may raise risk of persistent symptoms by 35%

By MedXY|Oct 4, 2025

Observational data from the RECOVER Initiative suggest that SARS-CoV-2 reinfection raises the risk of long COVID by 35% relative to single infections, with more recent vaccination potentially mitigating this risk.

Sex-Specific Impact of COVID-19 on Vascular Aging: Evidence from the CARTESIAN Study
CardiologyCOVID-19pulse wave velocity

Sex-Specific Impact of COVID-19 on Vascular Aging: Evidence from the CARTESIAN Study

By MedXY|Oct 4, 2025

COVID-19 accelerates vascular aging by approximately 5 years, disproportionately affecting women, with vaccination conferring protection primarily in females, highlighting sex-specific immunological responses and long-term vascular risks.

Razor Blade COVID-19 Variant Drives Up Cases in the U.S.
Infectious DiseasesCDCCOVID-19

Razor Blade COVID-19 Variant Drives Up Cases in the U.S.

By MedXY|Oct 4, 2025

The Stratus variant, known as XFG, now dominates COVID-19 cases in the U.S., complicating recovery efforts amidst rising infections and changing vaccine guidance.

CDC Retracts Universal COVID-19 Vaccination Recommendation for Pregnancy: Clinical Context, Evidence, and Implications
Medical NewsCDCCOVID-19

CDC Retracts Universal COVID-19 Vaccination Recommendation for Pregnancy: Clinical Context, Evidence, and Implications

By MedXY|Sep 30, 2025

The CDC no longer universally recommends COVID-19 vaccination during pregnancy, prompting debate among clinicians as the FDA shifts vaccine composition to target the JN.1 variant. This article analyzes the evidence, rationale, and clinical

Prev
2 / 2
12
Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities